Table 2 All children diagnosed with TB during the study period, differentiating between those diagnosed before and after HAART initiation
|  | Children treated for TB | TB diagnosed <9 months prior to HAART | TB diagnosed <6 months after HAART | TB diagnosed ≥6 months after HAART |
|---|---|---|---|---|
Total number # | 137 (100%) | 116 (100%) | 14 (100%) | 7 (100%) |
Gender: Male | 64 (47%) | 54 (47%) | 6 (43%) | 4 (57%) |
Age (months): | Â | Â | Â | Â |
Range/median | 2–140/18 | 2–135/20 | 3–140/17 | 3–75/17 |
HIV staging | Â | Â | Â | Â |
WHO* CD4 depletion | Â | Â | Â | Â |
   not significant | 5 (4%) | 3 (3%) | 1 (7%) | 0 (0%) |
   mild | 9 (7%) | 7 (6%) | 0 (0%) | 2 (29%) |
   advanced | 10 (7%) | 7 (6%) | 2 (14%) | 1 (14%) |
   severe | 113 (82%) | 98 (84%) | 11 (79%) | 4 (57%) |
WHO clinical stage | Â | Â | Â | Â |
   II | 1 (1%) | 0 (0%) | 1 (7%) | 0 (0%) |
   III | 47 (34%) | 40 (34%) | 5 (36%) | 2 (29%) |
   IV | 89 (65%) | 76 (66%) | 8 (57%) | 5 (71%) |
Weight categories | Â | Â | Â | Â |
   <60% EWA** | 27 (20%) | 24 (21%) | 3 (21%) | 0 (0%) |
   60–80% EWA | 64 (47%) | 51 (44%) | 7 (50%) | 6 (86%) |
   80–100% EWA | 34 (25%) | 31 (27%) | 3 (21%) | 0 (0%) |
   >100% EWA | 6 (4%) | 5 (4%) | 1 (7%) | 0 (0%) |
   Unknown | 6 (4%) | 5 (4%) | 0 (0%) | 1 (14%) |
Previous TB | Â | Â | Â | Â |
   1 episode | 18 (13%) | 12 (10%) | 5 (36%) | 1 (14%) |
   ≥2 episodes | 7 (5%) | 4 (3%) | 1 (7%) | 2 (29%) |